Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Spectranetics Corp.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Spectranetics Corp.

Regulatory records
4
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 4 FDA records to the applicant name Spectranetics Corp.. 2 entries are PMA supplements. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 18, 2025 to Aug 21, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LPC appears in 4 of the 4 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P910001, with 4 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 9965 Federal Dr., Colorado Springs, CO, 80921. Recorded on P910001/S127, decision dated Aug 21, 2026.

Changes described in PMA records

P910001/S126: ELCA Coronary Laser Atherectomy Catheters

FDA’s recorded scope: implementation of an automated inspection method for Excimer Laser Coronary Atherectomy (ELCA) Catheters (P910001) at both the in-process and final inspection steps

Aug 14, 2026 · 135 Review Track For 30-Day Notice

P910001/S124: ELCA Coronary Atherectomy Catheters

FDA’s recorded scope: the use of alternate components in the adhesive supplied to Philips/Spectranetics for the sterile barrier of the packaging system

Feb 6, 2026 · 135 Review Track For 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Devices & associated records

Product / regulatory recordCompanyPathwayDecision dateSource
Spectranetics Corp.PMA supplementAug 21, 2026FDA
Spectranetics Corp.PMA supplementAug 14, 2026FDA
Spectranetics Corp.PMA supplementFeb 6, 2026FDA
Spectranetics Corp.PMA supplementDec 18, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 20, 2026.